Opendata, web and dolomites

MINAPATH

MINAPATH: A novel and unique method to diagnose and prevent diseases that are caused by exposure and accumulation of inorganic mineral dusts.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MINAPATH project word cloud

Explore the words cloud of the MINAPATH project. It provides you a very rough idea of what is the project "MINAPATH" about.

combines    impacts    relationship    prevalence    feasibility    risk    accurate    nickel    quantitative    construction    finalise    idiopathic    metals    therapy    mostly    sites    expenditure    unknown    sustainability    minapath    effort    dusts    ageing    globally    fall    undiagnosed    diagnosis    healthcare    2050    billion    exposure    demonstrating    diseases    deposits    mineral    prepare    chronic    market    inflammatory    tests    category    once    financial    efficiency    underlying    cobalt    specially    silica    minerals    deteriorating    serving    occupational    asbestos    population    fast    commercial    despite    qualitative    lung    goals    stay    workplace    society    maturity    cadmium    progressing    influencing    environment    slowly    categorized    made    exclusion    quality    industrial    life    patient    cancer    pulmonary    exposome    diagnostic    diagnose    today    coming    carcinogenic    efficient    critical    hazard    people    settings    faces    unsustainable    carry   

Project "MINAPATH" data sheet

The following table provides information about the project.

Coordinator
MINAPATH DEVELOPPEMENT 

Organization address
address: 56 BD NIELS BOHR CENTRE D ENTREPRISE ET D INNOVATION 2
city: VILLEURBANNE
postcode: 69100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website https://www.minapath.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MINAPATH DEVELOPPEMENT FR (VILLEURBANNE) coordinator 50˙000.00

Map

 Project objective

Today healthcare faces critical challenges coming from an ageing population and the rise of chronic diseases. With a population expected to reach 9 billion people by 2050, healthcare expenditure is at risk of becoming unsustainable. Sustainability requires diagnostic methods to become more efficient, fast and accurate, to facilitate the use of adequate therapy. Despite the effort being made, there are still many diseases that get categorized as idiopathic (unknown cause). Specially in the lung, many inflammatory conditions fall under idiopathic category and stay undiagnosed, while slowly progressing, deteriorating the patient’s quality of life. However, many idiopathic conditions do have a common factor: exposure to mineral dusts such as asbestos, silica or metals (nickel, cadmium & cobalt). We are all at risk of exposure to these minerals, from the environment and workplace, being an occupational hazard in industrial settings and construction sites. Importantly, many of these mineral dusts are carcinogenic, contributing to the increasing prevalence of cancer globally. Despite their impact, today there are no dedicated diagnostic tests to assess mineral exposure, and diagnosis is mostly based on exclusion. In response, we at Minapath have developed a unique method that combines qualitative & quantitative analysis to diagnose the patient’s mineral exposome, serving to identify the underlying cause behind many cases of inflammatory & cancer conditions. After demonstrating the diagnostic relationship between mineral deposits and idiopathic pulmonary diseases, our goal with this project is to finalise the development of our technology and reach market maturity. To achieve these goals, in Phase 1 we aim to carry a Feasibility Study that help us prepare for the main technical, commercial and financial aspects influencing the project. Once completed, our technology will bring significant impacts to society and healthcare, contributing to its efficiency and sustainability.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MINAPATH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MINAPATH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

LTS (2020)

LEARNING TO SLEEP: INCREASING HEALTH THROUGH BETTER SLEEP

Read More